Uncover key drivers, emerging technologies, and competitive movements shaping the autotransfusion devices market from 2025–2034 with trusted insights from The Business Research Company
What Is The Base Market Size For The Autotransfusion Devices Market Today And What Will It Reach By 2029?
The autotransfusion devices market has experienced consistent expansion in recent years. It is projected to increase from $1.21 billion in 2024 to $1.26 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 4.4%. This historical growth can be attributed to a rise in surgical procedures, the prevalence of cardiovascular disease, an increase in orthopedic surgeries and joint replacements, a heightened focus on patient safety, and efforts to reduce blood transfusion costs.
The autotransfusion devices market size is anticipated to undergo significant expansion in the coming years. This market is forecasted to reach $1.67 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 7.2%. The expansion during the forecast period is primarily driven by the increasing geriatric population, the proliferation of ambulatory surgical centers, an emphasis on blood conservation strategies in obstetrics, and rising adoption in developing healthcare markets. Noteworthy trends expected in the forecast period encompass technological innovations in blood processing, the incorporation of advanced sensors, tailored customization for diverse medical procedures, the emergence of single-donor closed-loop systems, and the miniaturization of these devices.
Access A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10275&type=smp
What Factors Are Boosting The Autotransfusion Devices Market?
The rising incidence of cardiovascular diseases is projected to drive the growth of the autotransfusion device market in the coming years. Cardiovascular diseases (CVDs) are defined as a group of conditions that affect the heart and blood vessels. Autotransfusion devices play a role in minimizing the need for allogeneic blood transfusions. While allogeneic transfusions involve blood donated from outside sources, autotransfusion allows a patient’s own blood to be reinfused, thereby reducing the risks of transfusion reactions and complications associated with donor blood. For instance, according to the Heart Disease and Stroke Statistics-2022 Update report from the American Heart Association, a US-based non-profit organization, cardiovascular diseases (CVDs) remain the leading cause of death globally, accounting for an estimated 17.9 million lives each year. Therefore, the increasing prevalence of cardiovascular diseases is a key factor propelling the expansion of the autotransfusion device market.
How Is The Autotransfusion Devices Market Categorized By Application, Type, And Region?
The autotransfusion devicesmarket covered in this report is segmented –
1) By Product Type: Autotransfusion Systems, Consumables And Accessories
2) By Application: Cardiovascular Surgeries, Orthopedic Surgeries, Neurological Surgeries, Obstetrics And Gynecology Surgeries, Other Applications
3) By End-Use: Hospitals, Specialty Clinics, Other End Users
Subsegments:
1) By Autotransfusion Systems: Surgical Autotransfusion Systems, Emergency Autotransfusion Systems, Continuous Flow Autotransfusion Systems
2) By Consumables And Accessories: Collection Reservoirs, Blood Filters, Tubing Sets, Pumps, Anticoagulants
How Are Technological Trends Affecting The Autotransfusion Devices Market Growth?
Major companies engaged in the autotransfusion devices market are developing innovative products, such as next-generation intelligent control software, to boost efficiency and enhance user experience. This software upgrade, identified as Intelligent Control, delivers crucial enhancements to customers, simplifying operations and thereby supporting improved efficiency and a better user experience. For instance, in March 2023, Haemonetics, a US-based healthcare company, received FDA 510 (k) clearance for its next-generation Intelligent Control software for the Cell Saver Elite+ autotransfusion system. The Cell Saver Elite+ autotransfusion system is specifically designed to aid hospitals in recovering a patient’s blood during surgical procedures with the potential for medium to high blood loss, including cardiac, orthopedic, trauma, transplant, vascular, and OBGYN surgeries. The newly introduced Intelligent Control software signifies a substantial advancement within Haemonetics’ Cell Salvage platform and reinforces the company’s commitment to providing inventive solutions for superior patient outcomes.
Who Are The Global Leaders Steering The Autotransfusion Devices Market Forward?
Major companies operating in the autotransfusion devices market include Becton Dickinson And Company, Medtronic plc, LivaNova plc, Haemonetics Corporation, Fresenius SE & Co KGaA, Terumo Corporation, Asahi Kasei Medical Co. Ltd., B. Braun Melsungen AG, GE HealthCare Technologies Inc., Cerus Corporation, Stryker Corporation, Atrium Medical Technologies, Brightwake Ltd., Getinge AB, Beijing ZKSK Technology Co. Ltd., Braile Biomédica, Redax S.p.A., Teleflex Incorporated, Zimmer Biomet Holdings Inc., Gen World Medical Devices Corporation, Soma Technology International LLC, Beijing Jingjing Medical Equipment Co. Ltd., Johnson & Johnson Inc., Sorin Group, Baxter International Inc., Dideco, Nipro Corporation
Download The Full Report Here:
https://www.thebusinessresearchcompany.com/report/autotransfusion-devices-global-market-report
Which Region Is Projected To Achieve The Fastest Growth In The Autotransfusion Devices Market?
North America was the largest region in the autotransfusion devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global autotransfusion devices market during the forecast period. The regions covered in the autotransfusion devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Get A Report Customized For You Here:
https://www.thebusinessresearchcompany.com/customise?id=10275&type=smp
Browse Through More Reports Similar to the Global Autotransfusion Devices Market 2025, By The Business Research Company
Carbon Footprint Management Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/carbon-footprint-management-global-market-report
Environmental Technology Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/environmental-technology-global-market-report
Automatic Environmental Control Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
